Far Infrared Radiation for Sickle Cell Pain Management
This trial is active, not recruiting.
|Condition||anemia, sickle cell|
|Treatment||far infrared radiation (5μm to 20μm wavelength)|
|Sponsor||GAAD Medical Research Institute Inc.|
|Start date||January 2008|
|End date||September 2008|
|Trial size||10 participants|
|Trial identifier||NCT00599482, GAAD-SCC-CTP1|
Most patients with sickle-cell disease have periodic intensely painful episodes. To manage this pain, we are proposing the drinking of at least 500 mL of water followed by far infrared radiation.
|Endpoint classification||efficacy study|
|Intervention model||single group assignment|
|Primary purpose||supportive care|
Far Infrared Radiation
time frame: 40 minutes
Male or female participants of any age.
Inclusion Criteria: - People with sickle cell disease Exclusion Criteria: - None
|Official title||Phase 1 Study to Examine the Use of Far Infrared Radiation for Pain Management During Sickle Cell Crisis|
|Description||Painful sickle cell crises are treated with hydration and analgesics. Ischemia is an absolute or relative shortage of the blood supply to an organ. Relative shortage means the mismatch of blood supply (oxygen delivery) and blood request for adequate oxygenation of tissue. It is hereby postulated that far infrared radiation of the body will promote blood and oxygen supply to the affected tissues. In addition, the analgesic properties of far infrared will alleviate pain due to the crisis.|
Call for more information